👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Aequus Pharmaceuticals Inc (AQS)

TSXV
Currency in CAD
0.0100
0.0000(0.00%)
Closed
AQS Scorecard
Full Analysis
Stock has taken a big hit over the last week
Trading near 52-week Low
Fair Value
Day's Range
0.01000.0100
52 wk Range
0.01000.0500
Bid/Ask
0.01 / 0.015
Prev. Close
0.01
Open
0.01
Day's Range
0.01-0.01
52 wk Range
0.01-0.05
Volume
22,000
Average Volume (3m)
142,684
1-Year Change
-71.43%
Fair Value
Unlock
Fair Value Upside
Unlock
AQS Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility
Show more

Aequus Pharmaceuticals Inc Company Profile

Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on commercializing value-added products in specialty therapeutic areas in Canada. The company markets and distributes ZIMED PF, a preservative-free bimatoprost prescription drug for the treatment of glaucoma. It also develops REV-0100 for the treatment of stargardt disease that is in pre-clinical trial. The company has a strategic collaboration with reVision for the development of a therapy for stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Employees
0
Market
Canada

Compare AQS to Peers and Sector

Metrics to compare
AQS
Peers
Sector
Relationship
P/E Ratio
−0.5x−3.7x−0.6x
PEG Ratio
−0.140.010.00
Price/Book
−0.2x0.6x2.6x
Price / LTM Sales
4.8x1.4x3.2x
Upside (Analyst Target)
-314.9%47.1%
Fair Value Upside
Unlock19.4%7.1%Unlock

FAQ

What Is the Aequus Pharmaceuticals (AQS) Stock Price Today?

The Aequus Pharmaceuticals stock price today is 0.01

What Stock Exchange Does Aequus Pharmaceuticals Trade On?

Aequus Pharmaceuticals is listed and trades on the TSXV stock exchange.

What Is the Stock Symbol for Aequus Pharmaceuticals?

The stock symbol for Aequus Pharmaceuticals is "AQS."

What Is the Aequus Pharmaceuticals Market Cap?

As of today, Aequus Pharmaceuticals market cap is 1.33M.

What is Aequus Pharmaceuticals Earnings Per Share?

The Aequus Pharmaceuticals EPS is -0.022.

What Is the Next Aequus Pharmaceuticals Earnings Date?

Aequus Pharmaceuticals will release its next earnings report on Nov 27, 2024.

From a Technical Analysis Perspective, Is AQS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.